Alfresa Holdings Corporation Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 5/18/2026)
| Balance Sheet | Total Assets | 1,507,016,000,000.00 | ROE | 33.67 % |
| Balance Sheet | Total Equity | 507,358,000,000.00 | ROA | 2.77 % |
| Cashflow | Capital Expenditures | -22,457,000,000.00 | P/FCF | 25.65 |
| Cashflow | Free Cash Flow | 16,109,000,000.00 | – | – |
| Cashflow | Operating Cash Flow | 38,566,000,000.00 | P/CF | 10.71 |
| Income | Earnings per Share (diluted) | 229.74 | Div. Yield | 2.91 % |
| Income | Net Income | 41,746,000,000.00 | P/E | 9.90 |
| Income | Shares Outstanding | 181,713,000.00 | P/B | 0.81 |
| Income | Total Revenue | 3,104,064,000,000.00 | P/S | 0.13 |
Ratios calculated on: 10/14/2026
Company Description
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.alfresa.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more